AVITA Medical, Inc.: share-based compensation expense
Share-based compensation expense for AVITA Medical, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All AVITA Medical, Inc. financial histories
What this measure means
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
Exact concept: us-gaap:ShareBasedCompensation. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2017-07-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 9,519,000 | USD | 2026-02-12 | 10-K · 0001193125-26-049031 |
| 2024-01-01 | 2024-12-31 | 13,496,000 | USD | 2026-02-12 | 10-K · 0001193125-26-049031 |
| 2023-01-01 | 2023-12-31 | 8,384,000 | USD | 2025-02-13 | 10-K · 0000950170-25-020026 |
| 2022-01-01 | 2022-12-31 | 6,998,000 | USD | 2024-02-22 | 10-K · 0000950170-24-018748 |
| 2020-07-01 | 2021-06-30 | 5,664,000 | USD | 2023-02-23 | 10-K · 0001564590-23-002302 |
| 2019-07-01 | 2020-06-30 | 16,486,000 | USD | 2021-08-26 | 10-K · 0001564590-21-045962 |
| 2018-07-01 | 2019-06-30 | 1,946,000 | USD | 2021-08-26 | 10-K · 0001564590-21-045962 |
| 2017-07-01 | 2018-06-30 | 1,423,000 | USD | 2020-08-27 | 10-K · 0001193125-20-233145 |
Related financial histories
- AVITA Medical, Inc.: total assets
- AVITA Medical, Inc.: total liabilities
- AVITA Medical, Inc.: stockholders equity
- AVITA Medical, Inc.: cash and cash equivalents
- AVITA Medical, Inc.: net income or loss
- AVITA Medical, Inc.: operating cash flow
- AVITA Medical, Inc.: capital expenditure payments
- AVITA Medical, Inc.: revenue
- AVITA Medical, Inc.: financing cash flow
- AVITA Medical, Inc.: investing cash flow
- AVITA Medical, Inc.: retained earnings or deficit
- AVITA Medical, Inc.: basic weighted-average shares
- AVITA Medical, Inc.: diluted weighted-average shares
- AVITA Medical, Inc.: basic earnings per share
- AVITA Medical, Inc.: diluted earnings per share
- AVITA Medical, Inc.: income tax expense or benefit
- AVITA Medical, Inc.: net property, plant and equipment
- AVITA Medical, Inc.: operating income or loss
- AVITA Medical, Inc.: current assets
- AVITA Medical, Inc.: interest expense
- AVITA Medical, Inc.: current liabilities
- AVITA Medical, Inc.: net finite-lived intangible assets
- AVITA Medical, Inc.: net current accounts receivable
- AVITA Medical, Inc.: operating expenses
- AVITA Medical, Inc.: net inventory
- AVITA Medical, Inc.: gross profit
- AVITA Medical, Inc.: cost of revenue
- AVITA Medical, Inc.: research and development expense
Inspect the source
- Entity
- AVITA Medical, Inc. / CIK 0001762303
- Captured
- 2026-09-21T17:29:53.997Z
- SEC response SHA-256
49b6ed19f02b898849687084c1e3e18e128ba3153bd6915f427c3814d52c13f5
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001762303.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))